Investors

Press Releases

Overview
Press Releases     
 Events + Presentations
Company Information
Stock Information
SEC Filings
Corporate Governance
News Alerts

Recent Press Releases

Enveric Biosciences Announces Closing of MagicMed Industries Acquisition
September 17, 2021

Enveric Biosciences Announces MagicMed Industries' Presentations at the Following Investor Conferences in September
September 09, 2021

Enveric Biosciences CEO, David Johnson, Issues Letter to Shareholders
August 18, 2021

Enveric Biosciences Announces Approval from Israel's Ministry of Health to Begin its Phase 1/2 Trial of Triple-Combination CBD Treatment for Glioblastoma
July 08, 2021

Enveric Biosciences and MagicMed to Participate in June 2021 Investor and Industry Conferences
June 03, 2021

Enveric Biosciences Announces Definitive Agreement to Acquire MagicMed Industries, a Pharmaceutical Drug Discovery and Development Platform Focused on New-Generation Psychedelic Molecular Compounds and Derivatives
May 24, 2021

Enveric Biosciences Reports First Quarter 2021 Financial Results
May 18, 2021

Enveric Biosciences Appoints Dr. Arash Asher to Scientific Advisory Board
May 12, 2021

Enveric Biosciences to Participate in the Planet MicroCap Showcase on April 21st
April 14, 2021

Enveric Biosciences Appoints Carter Ward as Chief Financial Officer
April 12, 2021

Enveric Newsroom